Skip to main content

Drug Interactions between follicle stimulating hormone / ganirelix and Novarel

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

chorionic gonadotropin (HCG) ganirelix

Applies to: Novarel (chorionic gonadotropin (hcg)) and follicle stimulating hormone / ganirelix

ADJUST DOSE: Ganirelix can suppress the secretion of pituitary gonadotropins.

MANAGEMENT: A dose adjustment may be necessary when exogenous gonadotropins are used during controlled ovarian hyperstimulation.

References

  1. "Product Information. Antagon (ganirelix)." Organon PROD (2001):
  2. "Product Information. Trelstar (triptorelin)." Pharmacia and Upjohn PROD (2001):

Switch to consumer interaction data

Moderate

follicle stimulating hormone ganirelix

Applies to: follicle stimulating hormone / ganirelix and follicle stimulating hormone / ganirelix

ADJUST DOSE: Ganirelix can suppress the secretion of pituitary gonadotropins.

MANAGEMENT: A dose adjustment may be necessary when exogenous gonadotropins are used during controlled ovarian hyperstimulation.

References

  1. "Product Information. Antagon (ganirelix)." Organon PROD (2001):
  2. "Product Information. Trelstar (triptorelin)." Pharmacia and Upjohn PROD (2001):

Switch to consumer interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer